Factor H (CPV-104)

About Eleva

Eleva Biologics is a German, clinical-stage biotech leveraging a proprietary moss-based platform to develop novel biologics and cell therapies considered inaccessible by conventional systems. The company has built a pipeline initially targeting complement disorders and enzyme replacement therapies, with two candidates already in clinical development. Led by an experienced team, Eleva operates as a private, pre-revenue entity aiming to establish a broad portfolio of unique product candidates, both independently and through partnerships.

Therapeutic Areas